InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001179110-22-000400 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2022-01-11 2022-01-07 PTCT Almstead Neil Gregory Chief Technical Ops Off A - Grant $0.00 +780 2,490 +46% $0
DI 2022-01-11 2022-01-07 PTCT Almstead Neil Gregory Chief Technical Ops Off S - Sale $38.53 -45 1,710 -3% -$1,734
D 2022-01-11 2022-01-07 PTCT Almstead Neil Gregory Chief Technical Ops Off S - Sale $38.53 -756 35.1K -2% -$29.1K
D 2022-01-11 2022-01-07 PTCT Almstead Neil Gregory Chief Technical Ops Off A - Grant $0.00 +14.4K 49.5K +41% $0
D 2022-01-11 2022-01-07 PTCT Almstead Neil Gregory Chief Technical Ops Off A - Grant $0.00 +54.0K 54.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-07 A A 780 $0.00 2,490 I — — (F2) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
2 Common Common Stock 2022-01-07 S D 45 $38.53 1,710 I — — (F3) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 150 RSUs from a January 6, 2021 grant of 600 RSUs.
3 Common Common Stock 2022-01-07 S D 756 $38.53 35,058 D By Spouse — — (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 6, 2021 grant of 10,200 RSUs.
4 Common Common Stock 2022-01-07 A A 14,400 $0.00 49,458 D By Spouse — — (F2) Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
5 Derivative Stock Option (Right to Buy) 2022-01-07 A A 54,000 $0.00 54,000 D $38.10 · — to 2032-01-06 54,000 Common Stock (F4) This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.